Oncology

A Wealth of Experience

We have collaborated with our clients on projects to research cancer, cancer treatment, and complications and comorbidities of cancer. Our experience includes:

  • Basal cell carcinoma
  • Bladder cancer
  • Breast cancer
  • Cervical cancer
  • Colorectal cancer
  • Endometrial cancer
  • Gastric cancer
  • Glioblastoma multiforme
  • Head and neck cancer
  • Large B-cell lymphoma
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Melanoma
  • Myelofibrosis
  • Neuroendocrine tumors
  • Non-Hodgkin’s lymphoma
  • Renal cell carcinoma
  • Osteosarcoma
  • Ovarian cancer
  • Pancreatic cancer
  • Peritoneal cancers
  • Prostate cancer
  • Thyroid cancer

Types of Projects

We have implemented studies to help our clients develop strategies in the oncology market and to develop and gain 
market access for products to treat cancer and complications arising from treatment of cancer illnesses. 

Recent projects have included:

Our Experts

Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Melissa Juniper
Senior Director, Market Access and Outcomes Strategy
Keith Davis
Senior Director, Health Economics
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Dee Dee Mladsi (she/her)
Head, Health Economics—Strategy and Early Modeling
Christopher N. Graham
Senior Director, Health Economics
William L Herring
Senior Director, Health Economics
Christine Poulos
Senior Economist and Global Head, Health Preference Assessment
Anne Heyes
Vice President, Head Market Access and Outcomes Strategy, Europe
Alicia Gilsenan
Senior Director and Head, Epidemiology
Marco Boeri
Senior Economist
Jin Yang
Associate Director, Market Access and Outcomes Strategy
Chris Knight
Senior Director, Health Economics
Stephanie Barrows
Executive Director, Market Access and Outcomes Strategy
Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Jonathan Graham
Director, Health Economics
James Kaye
Senior Director, Epidemiology
Shahnaz Khan
Executive Director, Market Access and Outcomes Strategy
Ryan Ziemiecki
Director, Biostatistics
Mark Price
Senior Director, Health Economics
Costel Chirila
Director, Biostatistics
Katherine Stull
Director, Health Economics
Katherine Hicks
Senior Director, Health Economics
Michele Wilson
Senior Director, Health Economics
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Carol Mansfield
Senior Economist and Head, Health Preference Assessment
Marci Clark
Director, Patient-Centered Outcomes Assessment
Anita Brogan
Head, Decision Analytic Modeling, Health Economics
Juliana Meyers
Director, Health Economics
Elizabeth B. Andrews
Vice President, Emeritus, Epidemiology
Shaun Abeysinghe
Senior Director, Data Analytics and Design Strategy
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Lia Gutierrez
Senior Director, Epidemiology
Lori McLeod
Vice President, Patient-Centered Outcomes Assessment
Dawn Odom
Vice President, Biostatistics
Joan Fortuny
Director, Epidemiology
Sean Candrilli
Vice President, Health Economics
Sorrel Wolowacz
Head, European Health Economics
Annete Njue
Senior Director, Market Access and Outcomes Strategy
Xiaolei Zhou
Director, Biostatistics
Bintu Sherif
Director, Biostatistics
Isobel Pearson
Senior Director, Health Economics, Health Technology Assessment
Kelly Hollis
Vice President, Surveys and Observational Studies
Caroline Ling
Executive Director and HTA Specialist, Market Access and Outcomes Strategy
Colleen Castro
Associate Director, Market Access and Outcomes Strategy
Kenneth J Rothman
Distinguished Fellow, Vice President of Epidemiology Research
Jianmin Wang
Senior Statistician, Biostatistics

Selected Recent Oncology Publications